118
Views
3
CrossRef citations to date
0
Altmetric
Article

Integrated Analysis of lncRNAs and mRNAs Identifies a Potential Driver lncRNA FENDRR in Lung Cancer in Xuanwei, China

, , , , , , , , & show all
Pages 983-995 | Received 15 Dec 2019, Accepted 27 May 2020, Published online: 26 Jun 2020

References

  • Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.21262
  • Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.21338
  • Hosgood HD, Vermeulen R, Wei H, Reiss B, Coble J, Wei F, Jun X, Wu G, Rothman N, Lan Q, et al. Combustion-derived nanoparticle exposure and household solid fuel use in Xuanwei and Fuyuan, China. Int J Environ Health Res. 2012;22(6):571–581. doi:10.1080/09603123.2012.684147
  • Chen G, Sun X, Ren H, Wan X, Huang H, Ma X, Ning B, Zou X, Hu W, Yang G, et al. The mortality patterns of lung cancer between 1990 and 2013 in Xuanwei, China. Lung Cancer. 2015;90(2):155–160. doi:10.1016/j.lungcan.2015.08.006
  • Lan Q, Chapman RS, Schreinemachers DM, Tian L, He X. Household stove improvement and risk of lung cancer in Xuanwei, China. J Natl Cancer Inst. 2002;94(11):826–835. doi:10.1093/jnci/94.11.826
  • Shen M, Chapman RS, He X, Liu LZ, Lai H, Chen W, Lan Q. Dietary factors, food contamination and lung cancer risk in Xuanwei, China. Lung Cancer. 2008;61(3):275–282. doi:10.1016/j.lungcan.2007.12.024
  • Lan Q, He X, Shen M, Tian L, Liu LZ, Lai H, Chen W, Berndt SI, Hosgood HD, Lee K-M, et al. Variation in lung cancer risk by smoky coal subtype in Xuanwei, China. Int J Cancer. 2008;123(9):2164–2169. doi:10.1002/ijc.23748
  • Barone-Adesi F, Chapman RS, Silverman DT, He X, Hu W, Vermeulen R, Ning B, Fraumeni JF, Rothman N, Lan Q, et al. Risk of lung cancer associated with domestic use of coal in Xuanwei, China: retrospective cohort study. BMJ. 2012;345:e5414. doi:10.1136/bmj.e5414
  • Chen Y, Xiao Y, Yang Y, Duan J, Xu W. Decomposing contribution of age and non-age factors to rapid growth of lung cancer in Xuanwei over past 30 years. BMC Public Health. 2015;15:1116. doi:10.1186/s12889-015-2482-y
  • Hecht SS. Lung carcinogenesis by tobacco smoke. Int J Cancer. 2012;131(12):2724–2732. doi:10.1002/ijc.27816
  • Wu H, Meng S, Xu Q, Wang X, Wang J, Gong R, Song Y, Duan Y, Zhang Y. Gene expression profiling of lung adenocarcinoma in Xuanwei, China. Eur J Cancer Prev. 2016;25(6):508–517. doi:10.1097/CEJ.0000000000000214
  • Zhang Y, Xue Q, Pan G, Meng QH, Tuo X, Cai X, Chen Z, Li Y, Huang T, Duan X, et al. Integrated analysis of genome-wide copy number alterations and gene expression profiling of lung cancer in Xuanwei, China. PLoS One. 2017;12(1):e0169098. doi:10.1371/journal.pone.0169098
  • Yan X, Hu Z, Feng Y, Hu X, Yuan J, Zhao SD, Zhang Y, Yang L, Shan W, He Q, et al. Comprehensive genomic characterization of long non-coding RNAs across human cancers. Cancer Cell. 2015;28(4):529–540. doi:10.1016/j.ccell.2015.09.006
  • Weiss M, Plass C, Gerhauser C. Role of lncRNAs in prostate cancer development and progression. Biol Chem. 2014;395(11):1275–1290. doi:10.1515/hsz-2014-0201
  • Sun T-T, He J, Liang Q, Ren L-L, Yan T-T, Yu T-C, Tang J-Y, Bao Y-J, Hu Y, Lin Y, et al. LncRNA GClnc1 promotes gastric carcinogenesis and may act as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern. Cancer Discov. 2016;6(7):784–801. doi:10.1158/2159-8290.CD-15-0921
  • Li H, Yu B, Li J, Su L, Yan M, Zhu Z, Liu B. Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer. Oncotarget. 2014;5(8):2318–2329. doi:10.18632/oncotarget.1913
  • Zheng Y, Song D, Xiao K, Yang C, Ding Y, Deng W, Tong S. LncRNA GAS5 contributes to lymphatic metastasis in colorectal cancer. Oncotarget. 2016;7(50):83727–83734. doi:10.18632/oncotarget.13384
  • Iguchi T, Uchi R, Nambara S, Saito T, Komatsu H, Hirata H, Ueda M, Sakimura S, Takano Y, Kurashige J, et al. A long noncoding RNA, lncRNA-ATB, is involved in the progression and prognosis of colorectal cancer. Anticancer Res. 2015;35(3):1385–1388.
  • Liu Y, Zhang M, Liang L, Li J, Yx C. Over-expression of lncRNA DANCR is associated with advanced tumor progression and poor prognosis in patients with colorectal cancer. Int J Clin Exp Pathol. 2015;8:11480–11484.
  • Lv W, Yu X, Li W, Feng N, Feng T, Wang Y, Lin H, Qian B. Low expression of LINC00982 and PRDM16 is associated with altered gene expression, damaged pathways and poor survival in lung adenocarcinoma. Oncol Rep. 2018;40(5):2698–2709. doi:10.3892/or.2018.6645
  • Bassett AR, Akhtar A, Barlow DP, Bird AP, Brockdorff N, Duboule D, Ephrussi A, Ferguson-Smith AC, Gingeras TR, Haerty W, et al. Considerations when investigating lncRNA function in vivo. Elife. 2014;3:e03058. doi:10.7554/eLife.03058
  • Xue X, Yang YA, Zhang A, Fong K-W, Kim J, Song B, Li S, Zhao JC, Yu J. LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer. Oncogene. 2016;35(21):2746–2755. doi:10.1038/onc.2015.340
  • Liu Y, Zhao J, Zhang W, Gan J, Hu C, Huang G, Zhang Y. lncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer. Sci Rep. 2015;5:10159. doi:10.1038/srep10159
  • Cheng H, Huang CM, Wang Y, Hu XX, Xu XQ, Song XM, Tang GS, Chen L, Yang JM. Microarray profiling and co-expression network analysis of the lncRNAs and mRNAs associated with acute leukemia in adults. Mol Biosyst. 2017;13(6):1102–1108. doi:10.1039/c6mb00874g
  • Wang Y, Zhang H, Li X, Chen W. Differential expression profile analysis of lncRNA UCA1α regulated mRNAs in bladder cancer. J Cell Biochem. 2018;119(2):1841–1854. doi:10.1002/jcb.26345
  • Li R, Liu Y, Wang T, Tang J, Xie L, Yao Z, Li K, Liao Y, Zhou L, Geng Z, et al. The characteristics of lung cancer in Xuanwei County: a review of differentially expressed genes and noncoding RNAs on cell proliferation and migration. Biomed Pharmacother. 2019;119:109312. doi:10.1016/j.biopha.2019.109312
  • Li W-X, Dai S-X, Wang Q, Guo Y-C, Hong Y, Zheng J-J, Liu J-Q, Liu D, Li G-H, Huang J-F, et al. Integrated analysis of ischemic stroke datasets revealed sex and age difference in anti-stroke targets. PeerJ. 2016;4:e2470. doi:10.7717/peerj.2470
  • Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43):15545–15550. doi:10.1073/pnas.0506580102
  • Han H, Shim H, Shin D, Shim JE, Ko Y, Shin J, Kim H, Cho A, Kim E, Lee T, et al. TRRUST: a reference database of human transcriptional regulatory interactions. Sci Rep. 2015;5:11432. doi:10.1038/srep11432
  • Liu Q, Li A, Tian Y, Liu Y, Li T, Zhang C, Wu JD, Han X, Wu K. The expression profile and clinic significance of the SIX family in non-small cell lung cancer. J Hematol Oncol. 2016;9(1):119. doi:10.1186/s13045-016-0339-1
  • Ozturk S, Papageorgis P, Wong CK, Lambert AW, Abdolmaleky HM, Thiagalingam A, Cohen HT, Thiagalingam S. SDPR functions as a metastasis suppressor in breast cancer by promoting apoptosis. Proc Natl Acad Sci USA. 2016;113(3):638–643. doi:10.1073/pnas.1514663113
  • Sun Q, Zhang W, Wang L, Guo F, Song D, Zhang Q, Zhang D, Fan Y, Wang J. Hypermethylated CD36 gene affected the progression of lung cancer. Gene. 2018;678:395–406. doi:10.1016/j.gene.2018.06.101
  • Fadous-Khalifé MC, Aloulou N, Jalbout M, Hadchity J, Aftimos G, Paris F, Hadchity E. Krüppel-like factor 4: a new potential biomarker of lung cancer. Mol Clin Oncol. 2016;5(1):35–40. doi:10.3892/mco.2016.883
  • Jia Y, Ying X, Zhou J, Chen Y, Luo X, Xie S, Wang QC, Hu W, Wang L. The novel KLF4/PLAC8 signaling pathway regulates lung cancer growth. Cell Death Dis. 2018;9(6):603–620. doi:10.1038/s41419-018-0580-3
  • Donner I, Katainen R, Sipilä LJ, Aavikko M, Pukkala E, Aaltonen LA. Germline mutations in young non-smoking women with lung adenocarcinoma. Lung Cancer. 2018;122:76–82. doi:10.1016/j.lungcan.2018.05.027
  • Pircher A, Fiegl M, Untergasser G, Heidegger I, Medinger M, Kern J, Hilbe W. Favorable prognosis of operable non-small cell lung cancer (NSCLC) patients harboring an increased expression of tumor endothelial markers (TEMs). Lung Cancer. 2013;81(2):252–258. doi:10.1016/j.lungcan.2013.04.014
  • Wei H-J, Nickoloff JA, Chen W-H, Liu H-Y, Lo W-C, Chang Y-T, Yang P-C, Wu C-W, Williams DF, Gelovani JG, et al. FOXF1 mediates mesenchymal stem cell fusion-induced reprogramming of lung cancer cells. Oncotarget. 2014;5(19):9514–9529. doi:10.18632/oncotarget.2413
  • Suzuki M, Shiraishi K, Eguchi A, Ikeda K, Mori T, Yoshimoto K, Ohba Y, Yamada T, Ito T, Baba Y, et al. Aberrant methylation of LINE-1, SLIT2, MAL and IGFBP7 in non-small cell lung cancer. Oncol Rep. 2013;29(4):1308–1314. doi:10.3892/or.2013.2266
  • Tilley SK, Kim WY, Fry RC. Analysis of bladder cancer tumor CpG methylation and gene expression within The Cancer Genome Atlas identifies GRIA1 as a prognostic biomarker for basal-like bladder cancer. Am J Cancer Res. 2017;7(9):1850–1862.
  • Meng L, Xu Y, Xu C, Zhang W. Biomarker discovery to improve prediction of breast cancer survival: using gene expression profiling, meta-analysis, and tissue validation. OncoTargets Ther. 2016;9:6177–6185. doi:10.2147/OTT.S113855
  • Liu J, Liu Z, Liu Q, Li L, Fan X, Wen T, An G. CLEC3B is downregulated and inhibits proliferation in clear cell renal cell carcinoma. Oncol Rep. 2018;40:2023–2035. doi:10.3892/or.2018.6590
  • Yang L, Wu D, Chen J, Chen J, Qiu F, Li Y, Liu L, Cao Y, Yang B, Zhou Y, et al. A functional CNVR_3425.1 damping lincRNA FENDRR increases lifetime risk of lung cancer and COPD in Chinese. Carcinogenesis. 2018;39(3):347–359. doi:10.1093/carcin/bgx149
  • Xu T-p, Huang M-d, Xia R, Liu X-x, Sun M, Yin L, Chen W-m, Han L, Zhang E-b, Kong R, et al. Decreased expression of the long non-coding RNA FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates gastric cancer cell metastasis by affecting fibronectin1 expression. J Hematol Oncol. 2014;7(1):63. doi:10.1186/s13045-014-0063-7
  • Chen R, Wang Y, Duan Y, Zhang Y, Song G, et al. Effect of lncRNA FENDRR on proliferation, migration and invasion of the Xuanwei lung carcinoma XWLC-05 cell. Chin J Cancer Biother. 2017;24:727–732.
  • Yu T, Chen X, Zhang W, Liu J, Avdiushko R, Napier DL, Liu AX, Neltner JM, Wang C, Cohen D, et al. KLF4 regulates adult lung tumor-initiating cells and represses K-Ras-mediated lung cancer. Cell Death Differ. 2016;23(2):207–215. doi:10.1038/cdd.2015.85
  • Mateen S, Raina K, Jain AK, Agarwal C, Chan D, Agarwal R. Epigenetic modifications and p21-cyclin B1 nexus in anticancer effect of histone deacetylase inhibitors in combination with silibinin on non-small cell lung cancer cells. Epigenetics. 2012;7(10):1161–1172. doi:10.4161/epi.22070
  • Roy S, Kaur M, Agarwal C, Tecklenburg M, Sclafani RA, Agarwal R. p21 and p27 induction by silibinin is essential for its cell cycle arrest effect in prostate carcinoma cells. Mol Cancer Ther. 2007;6(10):2696–2707. doi:10.1158/1535-7163.MCT-07-0104

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.